USPTO serial 99577697
CopyMark Law Group can help you respond to USPTO correspondence, keep a registration alive, or watch new filings against your mark.
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
Mark Smith
Bermuda Dunes, CA, US
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Prescription pharmaceutical preparations for human use for the treatment of hematological cancers | ACTIVE | — |
| Date | Code | Event |
|---|---|---|
| Aug 18, 2026 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Jun 26, 2026 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Jun 26, 2026 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Jun 26, 2026 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Mar 27, 2026 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Mar 27, 2026 | GNRT | NON-FINAL ACTION E-MAILED |
| Mar 27, 2026 | CNRT | NON-FINAL ACTION WRITTEN |
| Mar 24, 2026 | DOCK | ASSIGNED TO EXAMINER |
| Jan 5, 2026 | MAFR | APPLICATION FILING RECEIPT MAILED |
| Jan 5, 2026 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Jan 5, 2026 | NWAP | NEW APPLICATION ENTERED |